When horses received treatment with IV DSP, ΔP max decreased from D0 to D7, but this decrease did not reach statistical significance after adjusting for multiple comparisons ( P = .06; Figure 2 ).
← all excerpts
A randomized, masked, crossover, clinical trial of the efficacy and safety of nebulized albuterol sulfate and dexamethasone sodium phosphate in asthmatic horses.
2
0.0600
0.0600
The sentences
20 Treatment resulted in a 38% decrease in BALF neutrophils (53 ± 32% to 33 ± 19%) but did not achieve significance.